The UK government will launch a targeted, one-off vaccination programme against meningitis B (MenB) this July for teenagers and young adults entering university. This emergency response follows an unprecedented outbreak in Kent and additional case clusters in Dorset and Berkshire that resulted in three deaths. Eligible individuals include those born between 1 September 2007 and 31 August 2008, as well as students under 25 entering residential higher education settings for the first time this autumn, according to Health Secretary James Murray.
Who is eligible for the MenB vaccine?
The programme targets two distinct groups considered to be at the highest risk for bacterial meningitis. According to the UK Health Security Agency (UKHSA), this includes all teenagers of year-13 age in England and Wales—or the equivalent school years in Scotland and Northern Ireland—and any student under 25 moving into university or residential further education for the first time. The initiative covers approximately one million young people, stated Dr. Shamez Ladhani, a consultant epidemiologist at the UKHSA. NHS England director of vaccination Caroline Temmink confirmed that eligible students will be contacted via the NHS app, text, or email, while pharmacy bookings will also be available for university entrants.
Why is this happening now?
The decision represents an emergency outbreak response rather than an update to the routine childhood immunisation schedule. While the MenB vaccine, Bexsero, has been part of the routine NHS programme for babies since 2015, older teenagers have historically only been offered the MenACWY vaccine. Health Secretary James Murray noted that recent clusters indicate a potential shift in how MenB affects the population. The UKHSA reports that cases of invasive meningococcal disease typically peak between October and November, making the summer vaccination window critical for preventing serious illness as students congregate in large social networks and shared accommodation.
How does the MenB vaccine work?
The Bexsero vaccine is administered in two doses, spaced at least 28 days apart. According to clinical data, it protects against the majority of MenB bacterial strains, with experts estimating that the resulting immunity lasts at least six years. MenB bacteria often reside harmlessly in the throat or nose but can cause life-threatening infections, including meningitis and septicaemia (blood poisoning). The NHS warns that one in 10 cases of bacterial meningitis is fatal, and survivors may face permanent complications like hearing loss or epilepsy.
What are the future trends for meningitis immunisation?
The current programme has sparked a debate regarding the long-term strategy for meningitis prevention. While the National Union of Students (NUS) has welcomed the move, vice president Alex Stanley stated that there should be no cost barrier to such vaccines and expressed hope that this becomes a regular feature of public health policy. Professor Adam Finn of the Bristol Children’s Vaccine Centre noted that the “one-off” nature of the announcement reflects the ongoing difficulty in balancing the cost-benefit analysis of mass immunising young adults against the relatively small number of annual cases. The Joint Committee on Vaccination and Immunisation (JCVI) is currently reviewing whether to expand the programme permanently.
Frequently Asked Questions
Is the MenB vaccine mandatory for university students?
No, the vaccine is not mandatory, but the government strongly encourages all eligible students to receive both doses to reduce the risk of serious illness.
Does the MenACWY vaccine protect against MenB?
No. The MenACWY vaccine protects against four other groups of meningococcal bacteria, but it does not cover the MenB strain.
Where can I get the vaccine?
Eligible students will be contacted by the NHS. Those under 25 starting university can also book appointments directly through participating pharmacies.
Have questions about your vaccination status or upcoming university health requirements? Share your thoughts in the comments below or subscribe to our health newsletter for the latest updates on student wellness.
